Number of Shares
11,213.00
Current Holdings Value*
$712,590.00
% of Portfolio
0.55%
Total Estimate Gain
$-403,972.70
% of Total Estimate Gain
-8.72%

MML Small Cap Growth Equity Fund's Haemonetics Corp Holding Summary

As of 2025-03-31, MML SERIES INVESTMENT FUND held 11,213.00 shares of Haemonetics Corp(HAE), totaling $712,590.00. This investment constitutes 0.55% of their stock portfolio, and MML SERIES INVESTMENT FUND now holds 0.02% of the outstanding Haemonetics Corp(HAE) stock.

The initial trade took place in 2019Q3. And since then MML Small Cap Growth Equity Fund has made 6 purchases of HAE, at an average price of $95.46, for a total of 48,559.00 shares. In addition, there have been 10 sales at an average price of $90.22 for 37,346.00 shares. Based on historical transaction data and HAE's current price of $76.87, MML Small Cap Growth Equity Fund's estimated gain on his HAE holdings is $-403,972.70, reflecting a -8.72% gain to date.

MML Small Cap Growth Equity Fund HAE ($76.87) Holding Chart

MML Small Cap Growth Equity Fund HAE ($76.87) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1